Is metronidazole (Flagyl) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Use During Pregnancy

Metronidazole should be avoided during the first trimester of pregnancy but can be safely used after the first trimester when clinically indicated. 1

Safety Profile by Trimester

First Trimester

  • Metronidazole is contraindicated during the first trimester of pregnancy 1
  • This recommendation is based on the precautionary principle, as the drug crosses the placental barrier rapidly 2

Second and Third Trimesters

  • Metronidazole can be safely administered after the first trimester 1
  • For trichomoniasis treatment after first trimester: 2g oral metronidazole as a single dose is recommended 1
  • For bacterial vaginosis during pregnancy: metronidazole 250mg orally three times daily for 7 days is preferred 1

Evidence on Safety

  • The FDA classifies metronidazole as pregnancy category B, indicating no evidence of harm to the fetus in animal studies 2
  • Multiple studies and meta-analyses have not demonstrated a consistent association between metronidazole use during pregnancy and teratogenic or mutagenic effects in newborns 1
  • A prospective controlled cohort study of 228 women exposed to metronidazole in pregnancy (86.2% with first-trimester exposure) found no difference in the rate of major malformations compared to controls (1.6% vs. 1.4%) 3
  • A review of nearly four decades of literature indicates that metronidazole is not teratogenic, regardless of the trimester in which it is used 4

Clinical Indications During Pregnancy

  • Trichomoniasis: Treatment is recommended for symptomatic pregnant women, particularly after the first trimester 1
  • Bacterial vaginosis: Treatment is recommended for all symptomatic pregnant women 1
  • Inflammatory bowel disease: Metronidazole can be given for pouchitis, perianal Crohn's disease, or intra-abdominal abscesses 1

Potential Benefits of Treatment

  • Treatment of bacterial vaginosis in high-risk pregnant women (those with previous preterm delivery) has been shown to reduce preterm delivery in multiple randomized controlled trials 1
  • Untreated bacterial vaginosis and trichomoniasis are associated with adverse pregnancy outcomes including premature rupture of membranes, preterm labor, and preterm birth 1, 4

Dosing Considerations

  • For bacterial vaginosis during pregnancy: 250mg orally three times daily for 7 days (lower than the non-pregnant dose of 500mg twice daily) 1
  • For trichomoniasis after first trimester: 2g orally in a single dose 1

Cautions and Monitoring

  • Patients should be advised to avoid alcohol during treatment with metronidazole and for 24 hours afterward 5
  • For high-risk pregnant women treated for bacterial vaginosis, a follow-up evaluation 1 month after completion of treatment should be considered 1

Important Caveats

  • Some evidence suggests that metronidazole used alone in the second trimester may be associated with increased risk of preterm delivery in high-risk populations 6
  • Clindamycin 300mg orally twice daily for 7 days is an alternative for patients with allergy or intolerance to metronidazole 1

The decision to use metronidazole during pregnancy should balance the risks of untreated infection against the potential risks of the medication, with particular caution during the first trimester.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Metronidazole appears not to be a human teratogen: review of literature.

Infectious diseases in obstetrics and gynecology, 1997

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The effect of second-trimester antibiotic therapy on the rate of preterm birth.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.